|
Volumn 51, Issue 3, 2010, Pages 609-
|
Invited commentary. Efficacy and safety of alfimeprase in patients with acute peripheral arterial occlusion (PAO).
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALFIMEPRASE;
FIBRINOLYTIC AGENT;
METALLOPROTEINASE;
ACUTE DISEASE;
CATHETERIZATION;
DRUG PULSE THERAPY;
FIBRINOLYTIC THERAPY;
GRAFT OCCLUSION;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
ISCHEMIA;
METHODOLOGY;
NOTE;
PERIPHERAL OCCLUSIVE ARTERY DISEASE;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
VASCULAR SURGERY;
ACUTE DISEASE;
ARTERIAL OCCLUSIVE DISEASES;
CATHETERIZATION, PERIPHERAL;
FIBRINOLYTIC AGENTS;
GRAFT OCCLUSION, VASCULAR;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
ISCHEMIA;
METALLOENDOPEPTIDASES;
PULSE THERAPY, DRUG;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RESEARCH DESIGN;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
VASCULAR SURGICAL PROCEDURES;
|
EID: 77950620290
PISSN: None
EISSN: 10976809
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (2)
|
References (0)
|